Skip to main content
. 2021 Aug 18;3(1):vdab104. doi: 10.1093/noajnl/vdab104

Figure 4.

Figure 4.

Inhibition of neurospheres in patient-derived glioma stem-like cells. (A) Representative micrographs of neurosphere formation on day-14 post (i) n-siRNAscrambled (ii) n-siRNAFAK (iii) n-siRNANOTCH-1 (iv) n-siRNASOX-2 (v) TMZ (vi) n-siRNAFNS, and (vii) TMZ+n-siRNAFNS. (B) Corresponding graphical representation of relative percentage neurosphere area, where the area of n-siRNAscrambled-treated group is assigned as 100%. Data are mean of 3 sample per patient ± standard deviation, *P < .001 against n-siRNAscrambled.